Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nicolaas Schaap"'
Autor:
Avichai Shimoni, Mark Ringhoffer, Gülsan Türköz Sucak, Herve Finel, Gwendolyn Van Gorkom, Sebastian Giebel, Nicolaas Schaap, David Pohlreich, Peter Dreger, Anna Sureda, Harry C. Schouten
Publikováno v:
Journal of Clinical Apheresis, 32(5), 295-301. Wiley
Journal of Clinical Apheresis, 32, 295-301
Journal of Clinical Apheresis, 32, 5, pp. 295-301
Journal of Clinical Apheresis, 32, 295-301
Journal of Clinical Apheresis, 32, 5, pp. 295-301
Item does not contain fulltext High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) to rescue hematopoiesis is considered standard care for patients with a relapsed chemosensitive lymphoma, but diagnosis of lymphoma has been
Autor:
Georg A. Böhmig, Morton J. Cowan, Nicolaas Schaap, Cyril Garrouste, E.M. Dauber, Søren Schwartz Sørensen, Michael Eder, Michael Kammer, Hideki Ishida, Anette Bachmann, Ulrich A. Duffner, Christoph Schwarz, Gabriela A. Berlakovich, Tepsiri Chongkrairatanakul, Sergio Alvarez, Thomas Wekerle, Rommel Ravanan, Niels Jacobsen, Michael Medinger, Heinz Regele, Martina Koch, Rainer Oberbauer, Robert S. Gaston, Brett Cullis, Masouridi Levrat Stavroula
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 19, iss 2
American Journal of Transplantation
Eder, M, Schwarz, C, Kammer, M, Jacobsen, N, Stavroula, M L, Cowan, M J, Chongkrairatanakul, T, Gaston, R, Ravanan, R, Ishida, H, Bachmann, A, Alvarez, S, Koch, M, Garrouste, C, Duffner, U A, Cullis, B, Schaap, N, Medinger, M, Sørensen, S S, Dauber, E-M, Böhmig, G, Regele, H, Berlakovich, G A, Wekerle, T & Oberbauer, R 2019, ' Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis ', American Journal of Transplantation, vol. 19, no. 2, pp. 475-487 . https://doi.org/10.1111/ajt.14970
American Journal of Transplantation, 19, 475-487
American Journal of Transplantation, 19, 2, pp. 475-487
American Journal of Transplantation
Eder, M, Schwarz, C, Kammer, M, Jacobsen, N, Stavroula, M L, Cowan, M J, Chongkrairatanakul, T, Gaston, R, Ravanan, R, Ishida, H, Bachmann, A, Alvarez, S, Koch, M, Garrouste, C, Duffner, U A, Cullis, B, Schaap, N, Medinger, M, Sørensen, S S, Dauber, E-M, Böhmig, G, Regele, H, Berlakovich, G A, Wekerle, T & Oberbauer, R 2019, ' Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis ', American Journal of Transplantation, vol. 19, no. 2, pp. 475-487 . https://doi.org/10.1111/ajt.14970
American Journal of Transplantation, 19, 475-487
American Journal of Transplantation, 19, 2, pp. 475-487
Tolerance induction through simultaneous hematopoietic stem cell and renal transplantation has shown promising results, but it is hampered by the toxicity of preconditioning therapies and graft‐versus‐host disease (GVHD). Moreover, renal function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3dc32622bc53d90ab112f3590d70c0f
https://escholarship.org/uc/item/0f16n45s
https://escholarship.org/uc/item/0f16n45s
Autor:
Natacha Maillard, Arnon Nagler, Vladimir Lazarevic, Jan J. Cornelissen, Jordi Esteve, Stig Lenhoff, Myriam Labopin, Ibrahim Yakoub-Agha, Mohamed Houhou, Wu Depei, Pietro Pioltelli, Anne Huynh, Nicolaas Schaap, Mohamad Mohty, Per Ljungman, Tobias Gedde-Dahl
Publikováno v:
American Journal of Hematology, 93, 1, pp. 31-39
American Journal of Hematology, 93, 31-39
American Journal of Hematology, 93(1), 31-39. Wiley-Liss Inc.
American Journal of Hematology, 93, 31-39
American Journal of Hematology, 93(1), 31-39. Wiley-Liss Inc.
The aim of the study was to assess the role of allogeneic stem cell transplantation (SCT) in patients diagnosed with BCR-ABL1-positive acute myeloid leukemia (AML). Fifty-seven patients (median age, 48 years, range: 19-67) with BCR-ABL1 positive AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4ff57f395f120f03d55a46f799e8791
https://hdl.handle.net/2066/184040
https://hdl.handle.net/2066/184040
Autor:
Pierre Zachee, Elliott F. Winton, Alessandro M. Vannucchi, Sonja Zweegman, Ruben A. Mesa, Joanne Lager, Harry C. Schouten, Claire N. Harrison, Jean-Jacques Kiladjian, Ramon V. Tiu, Moshe Talpaz, Francesco Passamonti, Richard T. Silver, Nicolaas Schaap, Eric Jourdan, Zhenming Shun
Publikováno v:
Harrison, C N, Schaap, N, Vannucchi, A M, Kiladjian, J J, Tiu, R V, Zachee, P, Jourdan, E, Winton, E, Silver, R T, Schouten, H C, Passamonti, F, Zweegman, S, Talpaz, M, Lager, J, Shun, Z & Mesa, R A 2017, ' Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2) : a single-arm, open-label, non-randomised, phase 2, multicentre study ', The Lancet Haematology, vol. 4, no. 7, pp. e317-e324 . https://doi.org/10.1016/S2352-3026(17)30088-1
Lancet Haematology, 4, 7, pp. e317-e324
Lancet Haematology, 4, e317-e324
The Lancet Haematology, 4(7), E317-E324. ELSEVIER SCI LTD
The Lancet Haematology, 4(7), e317-e324. Lancet Publishing Group
Lancet Haematology, 4, 7, pp. e317-e324
Lancet Haematology, 4, e317-e324
The Lancet Haematology, 4(7), E317-E324. ELSEVIER SCI LTD
The Lancet Haematology, 4(7), e317-e324. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: Myelofibrosis is a chronic myeloproliferative neoplasm characterised by splenomegaly, cytopenias, bone marrow fibrosis, and debilitating symptoms including fatigue, weight loss, and bone pain. Mutations in J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e26ba428c1b4f6196757a066ed54349
https://research.vumc.nl/en/publications/6d8e1497-f30c-4de7-81c0-86b1cbbdc6f1
https://research.vumc.nl/en/publications/6d8e1497-f30c-4de7-81c0-86b1cbbdc6f1
Autor:
Norbert Claude Gorin, Myriam Labopin, Didier Blaise, Arnon Nagler, Felicetto Ferrara, Sebastian Giebel, Alberto Bosi, Roberto M. Lemoli, Joan Hendrik Veelken, Tomasz Czerw, Arnaud Pigneux, Giovanna Meloni, Mohamad Mohty, Jan J. Cornelissen, Eric Beohou, Nicolaas Schaap
Publikováno v:
Cancer, 122, 1880-7
Cancer, 122(12), 1880-1887
Cancer, 122(12), 1880-1887. John Wiley & Sons Inc.
Cancer, 122, 12, pp. 1880-7
Cancer, 122(12), 1880-1887
Cancer, 122(12), 1880-1887. John Wiley & Sons Inc.
Cancer, 122, 12, pp. 1880-7
BACKGROUNDLeukemia recurrence is a major cause of treatment failure after autologous stem cell transplantation for acute myeloid leukemia (AML). It usually occurs within the first 2 years after transplantation. The goal of the current retrospective s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50e5756033f7c84729860419b8e9dca
http://hdl.handle.net/2066/170898
http://hdl.handle.net/2066/170898
Autor:
Nicole M. A. Blijlevens, Walter J.F.M. van der Velden, Aleida M. Liefferink, Lenneke F.J. van Groningen, Anton F.J. de Haan, J. Peter Donnelly, Nicolaas Schaap
Publikováno v:
Biology of Blood and Marrow Transplantation, 22, 1, pp. 179-82
ResearcherID
Web of Science
Biology of Blood and Marrow Transplantation, 22, 179-82
ResearcherID
Web of Science
Biology of Blood and Marrow Transplantation, 22, 179-82
Item does not contain fulltext Steroid-refractory acute graft-versus-host disease (aGVHD) remains an important cause of morbidity and mortality after allogeneic stem cell transplantation (SCT). A protocol on the management of aGVHD was introduced in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97c772e5c5d25194fc74433ebbd2eca
https://hdl.handle.net/2066/172152
https://hdl.handle.net/2066/172152
Autor:
Rianne Ammerlaan, Monique C. Minnema, Okke de Weerdt, Sonja Zweegman, Marie José Kersten, Marinus H. J. van Oers, Pieter Sonneveld, Reinier Raymakers, Nicolaas Schaap, Shulamiet Wittebol, Jan J. Cornelissen, Gerard M. J. Bos, Bronno van der Holt, Henk M. Lokhorst
Publikováno v:
Haematologica, 100(12), E508-E510. Ferrata Storti Foundation
Haematologica, 100, e508-10
Lokhorst, H M, van der Holt, B, Cornelissen, J J, Kersten, M J, van Oers, M, Raymakers, R, Minnema, M C, Zweegman, S, Bos, G, Schaap, N, Wittebol, S, de Weerdt, O, van Ammerlaan, R & Sonneveld, P 2015, ' Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival ', Haematologica, vol. 100, no. 12, pp. E508-E510 . https://doi.org/10.3324/haematol.2015.128728
Haematologica, 100(12), e508-e510. Ferrata Storti Foundation
Haematologica, 100, 12, pp. e508-10
Haematologica, 100, e508-10
Lokhorst, H M, van der Holt, B, Cornelissen, J J, Kersten, M J, van Oers, M, Raymakers, R, Minnema, M C, Zweegman, S, Bos, G, Schaap, N, Wittebol, S, de Weerdt, O, van Ammerlaan, R & Sonneveld, P 2015, ' Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival ', Haematologica, vol. 100, no. 12, pp. E508-E510 . https://doi.org/10.3324/haematol.2015.128728
Haematologica, 100(12), e508-e510. Ferrata Storti Foundation
Haematologica, 100, 12, pp. e508-10
Results of Allogeneic Stem Cell Transplantation (Allo-SCT) as part of first-line therapy for multiple myeloma (MM) are conflicting.1–7 The 96 month long-term followup of the EBMT trial showed a significantly prolonged PFS and OS for Auto-/Allo-SCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae256c3aba39f003c8994c6f593b7cc
https://research.vumc.nl/en/publications/69105eba-79a0-4058-88c2-26a140da059c
https://research.vumc.nl/en/publications/69105eba-79a0-4058-88c2-26a140da059c
Autor:
Mauricette Michallet, Stefan Schönland, Anja van Biezen, Sandra H. Thomas, Rose-Marie Hamljadi, T.J. de Witte, Lucía López-Corral, Peter Dreger, G. Gahrton, Xavier Poiré, Liisa Volin, Jacob Passweg, Nicolaas Schaap, Simona Iacobelli, Per Ljungman, A. Henseler, Firoozeh Sahebi, N Kröger, Laurent Garderet, Curly Morris
Publikováno v:
Bone Marrow Transplantation, 50, 6, pp. 802-7
Bone Marrow Transplantation, 50, 802-7
Bone Marrow Transplantation, 50, 802-7
Item does not contain fulltext We performed a retrospective analysis of the European Group for Blood and Marrow Transplantation database comparing the outcomes of multiple myeloma patients who received tandem autologous followed by allogeneic PSCT (a
Autor:
M.J. Rinkes, Th de Witte, Nicolaas Schaap, Wil A. Allebes, Irma Joosten, A. F. G. van der Meer, Anton Schattenberg, R.W.M. van der Maazen, Frank Preijers
Publikováno v:
Bone Marrow Transplantation, 33, 11, pp. 1115-21
Bone Marrow Transplantation, 33, 1115-21
Bone Marrow Transplantation, 33, 1115-21
Contains fulltext : 57804.pdf (Publisher’s version ) (Closed access) We retrospectively analysed the outcome of voluntary unrelated donor (VUD)-SCT in 56 patients after conditioning without or with ATG. All received partially lymphocyte-depleted gr
Autor:
Denis Caillot, Thibaut Leguay, Myriam Labopin, Mauricette Michallet, Norbert Claude Gorin, Mohamad Mohty, Nicolaas Schaap, Sebastian Giebel, Hervé Dombret
Publikováno v:
European Journal of Cancer, 50, 411-7
European Journal of Cancer, 50, 2, pp. 411-7
European Journal of Cancer, 50, 2, pp. 411-7
Contains fulltext : 138260.pdf (Publisher’s version ) (Closed access) BACKGROUND: Outcome of Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL) improved significantly with the introduction of tyrosine kinase inhibitors (TKIs). Autologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c121aaed90cb44976c911aec35aec625
https://doi.org/10.1016/j.ejca.2013.08.027
https://doi.org/10.1016/j.ejca.2013.08.027